Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2006
08/10/2006WO2006084284A2 Adipose derived adult stromal cells exhibiting characteristics of endothelial cells
08/10/2006WO2006084229A2 Use of nuclear material to therapeutically reprogram differentiated cells
08/10/2006WO2006084226A2 Antibodies that bind to epha2 and methods of use thereof
08/10/2006WO2006084040A2 Engineering vascularized muscle tissue
08/10/2006WO2006084035A2 Transgenic chickens
08/10/2006WO2006084006A1 Human antibodies against rabies and uses thereof
08/10/2006WO2006083936A2 Anti-ephb2 antibodies and methods using same
08/10/2006WO2006083782A2 Directed differentiation of embryonic stem cells and uses thereof
08/10/2006WO2006083394A2 Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
08/10/2006WO2006083133A2 Human embryonic stem cell created from an oocyte and a somatic cell derived from non-identical individuals and a method for preparing the same
08/10/2006WO2006082890A1 Method of inducing differentiation of embryo-stem cell into hepatocyte and hepatocyte induced by the method
08/10/2006WO2006082854A1 Process for producing chondrocyte preparation for transplantation
08/10/2006WO2006082851A1 Mucin relating to epiglycanin
08/10/2006WO2006082826A1 METHOD OF IDENTIFYING PURKINJE CELL TARGETING Corl2 GENE
08/10/2006WO2006082798A1 Monoclonal antibody specifically recognizing rat type i microglia
08/10/2006WO2006082763A1 Method of regenerating elastic fiber with the use of dance or factor enhancing the expression thereof
08/10/2006WO2006082385A1 Screening method
08/10/2006WO2006082270A1 Novel 3-d polymer scaffold for tissue regeneration and preparation method thereof
08/10/2006WO2006082254A2 Microorganisms comprising enzymes expressed with low gamma-elimination activity
08/10/2006WO2006081722A1 A purification and cultivation method of ocean sponge pluripotent stem cell
08/10/2006WO2006081620A1 Cd4+ cd25+ t-cells activated to a specific antigen
08/10/2006WO2006081619A1 Improving survival and proliferation of cd4+ and cd25+ t cells
08/10/2006WO2006060335A3 Cellular signaling pathway based assays, reagents and kits
08/10/2006WO2006059130A9 Manipulation of starch granule size and number (ii)
08/10/2006WO2006059081A3 Methods of treatment using melanopsin
08/10/2006WO2006059069A3 Ion channel
08/10/2006WO2006050270A3 Compositions and methods for treating hyperproliferative disorders
08/10/2006WO2006048459A3 Selection of host cells expressing protein at high levels
08/10/2006WO2006033688A3 Anti-lympho- plus anti-monocytes globulin preparation for inhibiting immune responses
08/10/2006WO2006026608A3 Transgenic mammals and cell lines for the identification of glutamate transporter modulators
08/10/2006WO2006024947A3 Methods and materials relating to enhanced production of dopamine neurons
08/10/2006WO2006023560A3 Eukaryotic translation initiation factor gene regulatory elements for use in plants
08/10/2006WO2006017855A3 Methods and compositions for regulation of stem cell survival, proliferation, and differentiation by protein ubiquitination
08/10/2006WO2005113749A3 Stem cell populations and methods of use
08/10/2006WO2005077048A3 Immune modulation by regulating expression of the “minor” gene in immune dendritic cells
08/10/2006WO2005021704A3 In vitro generation of gabaergic neurons from embryonic stem cells and their use in the treatment of neurological disorders
08/10/2006WO2003065999A3 Proliferated cell lines and uses thereof
08/10/2006WO2003000852A3 Method of producing region-specific neurons from human neuronal stem cells
08/10/2006US20060179515 Sugar and Lipid Metabolism Regulators in Plants
08/10/2006US20060179512 Nitrogen-regulated sugar sensing gene and protein and modulation thereof
08/10/2006US20060179511 Transgenic plants with enhanced agronomic traits
08/10/2006US20060179510 Inbred cantaloupe line I446
08/10/2006US20060179509 Soybean cultivar 4805442
08/10/2006US20060179508 Soybean cultivar 4921237
08/10/2006US20060179507 Nucleic acid encoding protein of given sequence; hydroxylation of taxoid; used in production of anti-cancer drugs paclitaxel and taxol
08/10/2006US20060179502 Automated gene-targeting using non-toxic detectable markers
08/10/2006US20060179501 Transgenic mice expressing human cd20
08/10/2006US20060179496 Nucleic acid sequences differentially expressed in cancer tissue
08/10/2006US20060179494 Non-human animal exhibiting bone metastasis of tumor cells
08/10/2006US20060178518 3'-[(2z)-[1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hy-drazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
08/10/2006US20060178503 Antibody to an integrin heterodimer and/or a subunit thereof
08/10/2006US20060178317 Methods of increasing endogenous erythropoietin (EPO)
08/10/2006US20060178316 Methods of increasing endogenous erythropoietin (EPO)
08/10/2006US20060178308 Complement inhibitor
08/10/2006US20060178297 Systems and methods for silencing expression of a gene in a cell and uses thereof
08/10/2006US20060177934 Lentiviral LTR-deleted vector
08/10/2006US20060177933 Expression of apoA-1 and variants thereof using spliceosome mediated RNA trans-splicing
08/10/2006US20060177932 Expansion agents for stem cells
08/10/2006US20060177931 Apparatus and method for co-culturing of cells
08/10/2006US20060177930 Method to enhance biodegradation of sulfonated aliphatic-aromatic co-polyesters by addition of a microbial consortium
08/10/2006US20060177929 Regulation of self-renewal in stem cells
08/10/2006US20060177928 Method of generating neural stem cells
08/10/2006US20060177927 Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering
08/10/2006US20060177926 Common marmoset embryonic stem cell lines
08/10/2006US20060177925 Kidney derived stem cells and methods for their isolation, differentiation and use
08/10/2006US20060177924 Seeding cells on porous supports
08/10/2006US20060177923 Spatially-defined modification of fresh tissue using covalent chemistry
08/10/2006US20060177915 Method for the production of glycerol by recombinant organisms
08/10/2006US20060177901 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
08/10/2006US20060177898 Methods for producing modified glycoproteins
08/10/2006US20060177897 PR1550 polypeptides and nucleic acids encoding the same
08/10/2006US20060177875 Tryptase polypeptide and uses thereof
08/10/2006US20060177872 Using paramagnetic microparticles coated with a purified recombinant porcine intrinsic factor and chemiluminescence as capture and visualization tools in detection and quantification of vitamin B12 in sample
08/10/2006US20060177865 Computational method for designing enzymes for incorporation of amino acid analogs into proteins
08/10/2006US20060177861 Novel compositions and methods in cancer associated with altered expression of MCM3AP
08/10/2006US20060177825 Global analysis of transposable elements as molecular markers of the developmental potential of stem cells
08/10/2006US20060177819 genetic engineered polynucleotides comprising nucleotide sequences that code alphavirus replication recognition sequences, nonstructural proteins and heterologous polynucleotides; infectious, replication-defective alphavirus particles used for immunotherapy, treatment of cancer and gene delivery
08/10/2006US20060177816 Cellular RhoGTPase activation assay
08/10/2006US20060177529 Aleurone product and corresponding production method
08/10/2006US20060177492 Collagen gel and process of producing the same
08/10/2006US20060177470 Dna sequence and recombinant production of the grass pollen allergen phl p4
08/10/2006US20060177466 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
08/10/2006US20060177463 Fusion polypeptide; includes a first polypeptide that is glycosylated by a alpha 1, 3/4 fucosyltransferase (FUT3), an alpha 1,2 fucosyltransferase (FUT2) and a beta 1,3 galactosyltransferase operably linked to a second polypeptide
08/10/2006US20060177456 Apo-2 receptor antibodies
08/10/2006US20060177455 Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same
08/10/2006US20060177453 Effective in inhibiting tumor cell growth; immunotherapy; purified immunoglobulin; preventing or delaying development of metastasis, treating metastatic cancer, or inhibiting proliferation of metastatic cancer cells
08/10/2006US20060177440 Compositions and methods for detection of antibody binding to cells
08/10/2006US20060177431 Inhibitors for continuous activation of calcineurin
08/10/2006US20060177428 Expression vector comprising nucleotide sequences coding endothelial growth factor for use in diagnosis, prevention and treatment of tumor disorders
08/10/2006US20060177420 treatment of a tumor by administering to a patient an effective amount of active dendritic cells (DC) that are tumor-specific and secrete IL12
08/10/2006US20060177386 Method of regenerating tooth germ and a regenerated tooth germ
08/10/2006DE60115222T2 Kombination von defibrotid und g-csf und ihre verwendung zur aktivierung hämatopoietischer vorläuferzellen Progenitor cell combination of defibrotide and g-csf and their use for the activation of hematopoietic
08/10/2006CA2827515A1 Site-specific serine recombinases and methods of their use
08/10/2006CA2613812A1 Directed differentiation of embryonic stem cells and uses thereof
08/10/2006CA2610632A1 Genetically engineered swine influenza virus and uses thereof
08/10/2006CA2597198A1 Antibodies that bind to epha2 and methods of use thereof
08/10/2006CA2597171A1 Antibodies to oncostatin m receptor
08/10/2006CA2596715A1 Screening method
08/10/2006CA2596697A1 Human antibodies against rabies and uses thereof
08/10/2006CA2596281A1 Adipose derived adult stromal cells exhibiting characteristics of endothelial cells